Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 13F-HR: SEC filing
About this filing
Regeneron Pharmaceuticals, Inc. (REGN) filed Form 13F-HR (sec filing) with the SEC on Nov 5, 2026.
Key facts
- Document
- —
More REGN filings
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 144
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.